Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Feb 07, 2024 1:53pm
97 Views
Post# 35867984

RE:RE:RE:Why is this dropping?

RE:RE:RE:Why is this dropping?Well I don't think we'll get above dollars without a partner and confirmed Ph III start date.

And I don't think today's price action will be the lowest... but expect we float around this level for a month or so, probably break 1 buck and fall again, then have a spike low to 78-79 cents before the recovery begins... I still think late March onwards.

Of course it would be nice if Matt would issue a letter to shareholders to explain as best he can what the situation on partners is, and right the ship a little. BY the time they get to the AGM there will only be 4-5 months of cash left... which is probably why many are bailing now.

So, Azzak, now you are below your entry price of 1.07 a share (that you shared with me back in Nov I think it was)... meanwhile of course... CRSP is up again by a small amount, whilst ONCY is down 11%... dang.

As for having the cojones to sell out when I did last November, and make good on my loss in Crispr... well, I think I won that bet don't you.?
<< Previous
Bullboard Posts
Next >>